nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Carmustine—brain cancer	0.238	0.351	CbGbCtD
Imiquimod—CYP3A4—Temozolomide—brain cancer	0.18	0.265	CbGbCtD
Imiquimod—CYP3A4—Lomustine—brain cancer	0.153	0.225	CbGbCtD
Imiquimod—CYP1A2—Etoposide—brain cancer	0.0704	0.104	CbGbCtD
Imiquimod—CYP3A4—Etoposide—brain cancer	0.0369	0.0545	CbGbCtD
Imiquimod—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00139	0.0619	CbGpPWpGaD
Imiquimod—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00126	0.0563	CbGpPWpGaD
Imiquimod—Pancytopenia—Carmustine—brain cancer	0.000922	0.00307	CcSEcCtD
Imiquimod—Myalgia—Procarbazine—brain cancer	0.00092	0.00306	CcSEcCtD
Imiquimod—Arthralgia—Procarbazine—brain cancer	0.00092	0.00306	CcSEcCtD
Imiquimod—Anxiety—Procarbazine—brain cancer	0.000917	0.00305	CcSEcCtD
Imiquimod—Sweating increased—Temozolomide—brain cancer	0.000913	0.00304	CcSEcCtD
Imiquimod—Bronchitis—Temozolomide—brain cancer	0.000902	0.003	CcSEcCtD
Imiquimod—Dry mouth—Procarbazine—brain cancer	0.0009	0.00299	CcSEcCtD
Imiquimod—Pancytopenia—Temozolomide—brain cancer	0.000891	0.00296	CcSEcCtD
Imiquimod—Cardiac failure—Etoposide—brain cancer	0.00089	0.00296	CcSEcCtD
Imiquimod—Vomiting—Lomustine—brain cancer	0.000883	0.00294	CcSEcCtD
Imiquimod—Oedema—Procarbazine—brain cancer	0.000882	0.00294	CcSEcCtD
Imiquimod—Dysuria—Temozolomide—brain cancer	0.000877	0.00292	CcSEcCtD
Imiquimod—Infection—Procarbazine—brain cancer	0.000876	0.00292	CcSEcCtD
Imiquimod—Angiopathy—Hydroxyurea—brain cancer	0.000872	0.0029	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Temozolomide—brain cancer	0.000872	0.0029	CcSEcCtD
Imiquimod—Shock—Procarbazine—brain cancer	0.000868	0.00289	CcSEcCtD
Imiquimod—Erectile dysfunction—Temozolomide—brain cancer	0.000864	0.00287	CcSEcCtD
Imiquimod—Depression—Carmustine—brain cancer	0.000863	0.00287	CcSEcCtD
Imiquimod—Chills—Hydroxyurea—brain cancer	0.000862	0.00287	CcSEcCtD
Imiquimod—Tachycardia—Procarbazine—brain cancer	0.000861	0.00286	CcSEcCtD
Imiquimod—Photosensitivity reaction—Temozolomide—brain cancer	0.000856	0.00285	CcSEcCtD
Imiquimod—Hyperhidrosis—Procarbazine—brain cancer	0.000853	0.00284	CcSEcCtD
Imiquimod—Alopecia—Hydroxyurea—brain cancer	0.000849	0.00283	CcSEcCtD
Imiquimod—Neuropathy peripheral—Carmustine—brain cancer	0.000848	0.00282	CcSEcCtD
Imiquimod—Urinary tract infection—Carmustine—brain cancer	0.000841	0.0028	CcSEcCtD
Imiquimod—Anorexia—Procarbazine—brain cancer	0.000841	0.0028	CcSEcCtD
Imiquimod—Erythema—Hydroxyurea—brain cancer	0.000836	0.00278	CcSEcCtD
Imiquimod—Infestation NOS—Temozolomide—brain cancer	0.000836	0.00278	CcSEcCtD
Imiquimod—Infestation—Temozolomide—brain cancer	0.000836	0.00278	CcSEcCtD
Imiquimod—Depression—Temozolomide—brain cancer	0.000834	0.00277	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000829	0.00276	CcSEcCtD
Imiquimod—Nausea—Lomustine—brain cancer	0.000825	0.00275	CcSEcCtD
Imiquimod—Neuropathy peripheral—Temozolomide—brain cancer	0.00082	0.00273	CcSEcCtD
Imiquimod—Urinary tract infection—Temozolomide—brain cancer	0.000813	0.0027	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000804	0.00267	CcSEcCtD
Imiquimod—Insomnia—Procarbazine—brain cancer	0.000798	0.00265	CcSEcCtD
Imiquimod—Paraesthesia—Procarbazine—brain cancer	0.000792	0.00264	CcSEcCtD
Imiquimod—Hepatobiliary disease—Temozolomide—brain cancer	0.000791	0.00263	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—SPP1—brain cancer	0.000788	0.0351	CbGpPWpGaD
Imiquimod—Sinusitis—Temozolomide—brain cancer	0.000784	0.00261	CcSEcCtD
Imiquimod—Somnolence—Procarbazine—brain cancer	0.000784	0.00261	CcSEcCtD
Imiquimod—Haemoglobin—Carmustine—brain cancer	0.000781	0.0026	CcSEcCtD
Imiquimod—Haemorrhage—Carmustine—brain cancer	0.000777	0.00258	CcSEcCtD
Imiquimod—Ill-defined disorder—Hydroxyurea—brain cancer	0.000776	0.00258	CcSEcCtD
Imiquimod—Decreased appetite—Procarbazine—brain cancer	0.000767	0.00255	CcSEcCtD
Imiquimod—Connective tissue disorder—Carmustine—brain cancer	0.000763	0.00254	CcSEcCtD
Imiquimod—Fatigue—Procarbazine—brain cancer	0.00076	0.00253	CcSEcCtD
Imiquimod—Haemoglobin—Temozolomide—brain cancer	0.000754	0.00251	CcSEcCtD
Imiquimod—Malaise—Hydroxyurea—brain cancer	0.000754	0.00251	CcSEcCtD
Imiquimod—Pain—Procarbazine—brain cancer	0.000754	0.00251	CcSEcCtD
Imiquimod—Haemorrhage—Temozolomide—brain cancer	0.000751	0.0025	CcSEcCtD
Imiquimod—Visual impairment—Carmustine—brain cancer	0.000748	0.00249	CcSEcCtD
Imiquimod—Pharyngitis—Temozolomide—brain cancer	0.000745	0.00248	CcSEcCtD
Imiquimod—Urinary tract disorder—Temozolomide—brain cancer	0.000741	0.00247	CcSEcCtD
Imiquimod—Connective tissue disorder—Temozolomide—brain cancer	0.000738	0.00245	CcSEcCtD
Imiquimod—Urethral disorder—Temozolomide—brain cancer	0.000736	0.00245	CcSEcCtD
Imiquimod—Sweating increased—Etoposide—brain cancer	0.000731	0.00243	CcSEcCtD
Imiquimod—Feeling abnormal—Procarbazine—brain cancer	0.000727	0.00242	CcSEcCtD
Imiquimod—Eye disorder—Carmustine—brain cancer	0.000726	0.00242	CcSEcCtD
Imiquimod—Convulsion—Hydroxyurea—brain cancer	0.000725	0.00241	CcSEcCtD
Imiquimod—Visual impairment—Temozolomide—brain cancer	0.000723	0.00241	CcSEcCtD
Imiquimod—Gastrointestinal pain—Procarbazine—brain cancer	0.000721	0.0024	CcSEcCtD
Imiquimod—Flushing—Carmustine—brain cancer	0.000721	0.0024	CcSEcCtD
Imiquimod—Pancytopenia—Etoposide—brain cancer	0.000713	0.00237	CcSEcCtD
Imiquimod—Erythema multiforme—Temozolomide—brain cancer	0.00071	0.00236	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000707	0.00235	CcSEcCtD
Imiquimod—Discomfort—Hydroxyurea—brain cancer	0.000704	0.00234	CcSEcCtD
Imiquimod—Eye disorder—Temozolomide—brain cancer	0.000701	0.00233	CcSEcCtD
Imiquimod—Urticaria—Procarbazine—brain cancer	0.000701	0.00233	CcSEcCtD
Imiquimod—Tinnitus—Temozolomide—brain cancer	0.0007	0.00233	CcSEcCtD
Imiquimod—Body temperature increased—Procarbazine—brain cancer	0.000697	0.00232	CcSEcCtD
Imiquimod—Abdominal pain—Procarbazine—brain cancer	0.000697	0.00232	CcSEcCtD
Imiquimod—Flushing—Temozolomide—brain cancer	0.000697	0.00232	CcSEcCtD
Imiquimod—Arrhythmia—Carmustine—brain cancer	0.000694	0.00231	CcSEcCtD
Imiquimod—Alopecia—Carmustine—brain cancer	0.000686	0.00228	CcSEcCtD
Imiquimod—Oedema—Hydroxyurea—brain cancer	0.000683	0.00227	CcSEcCtD
Imiquimod—Angiopathy—Temozolomide—brain cancer	0.000681	0.00227	CcSEcCtD
Imiquimod—Mental disorder—Carmustine—brain cancer	0.00068	0.00226	CcSEcCtD
Imiquimod—Infection—Hydroxyurea—brain cancer	0.000678	0.00226	CcSEcCtD
Imiquimod—Immune system disorder—Temozolomide—brain cancer	0.000678	0.00226	CcSEcCtD
Imiquimod—Mediastinal disorder—Temozolomide—brain cancer	0.000676	0.00225	CcSEcCtD
Imiquimod—Erythema—Carmustine—brain cancer	0.000676	0.00225	CcSEcCtD
Imiquimod—Malnutrition—Carmustine—brain cancer	0.000676	0.00225	CcSEcCtD
Imiquimod—Chills—Temozolomide—brain cancer	0.000673	0.00224	CcSEcCtD
Imiquimod—Nervous system disorder—Hydroxyurea—brain cancer	0.000669	0.00223	CcSEcCtD
Imiquimod—Infestation—Etoposide—brain cancer	0.000669	0.00223	CcSEcCtD
Imiquimod—Infestation NOS—Etoposide—brain cancer	0.000669	0.00223	CcSEcCtD
Imiquimod—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000667	0.0297	CbGpPWpGaD
Imiquimod—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000663	0.00221	CcSEcCtD
Imiquimod—Alopecia—Temozolomide—brain cancer	0.000663	0.00221	CcSEcCtD
Imiquimod—Skin disorder—Hydroxyurea—brain cancer	0.000663	0.00221	CcSEcCtD
Imiquimod—Acute coronary syndrome—Etoposide—brain cancer	0.00066	0.00219	CcSEcCtD
Imiquimod—Mental disorder—Temozolomide—brain cancer	0.000658	0.00219	CcSEcCtD
Imiquimod—Myocardial infarction—Etoposide—brain cancer	0.000656	0.00218	CcSEcCtD
Imiquimod—Neuropathy peripheral—Etoposide—brain cancer	0.000656	0.00218	CcSEcCtD
Imiquimod—Back pain—Carmustine—brain cancer	0.000654	0.00218	CcSEcCtD
Imiquimod—Erythema—Temozolomide—brain cancer	0.000653	0.00217	CcSEcCtD
Imiquimod—Malnutrition—Temozolomide—brain cancer	0.000653	0.00217	CcSEcCtD
Imiquimod—Anorexia—Hydroxyurea—brain cancer	0.000651	0.00217	CcSEcCtD
Imiquimod—Hypersensitivity—Procarbazine—brain cancer	0.00065	0.00216	CcSEcCtD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000642	0.0286	CbGpPWpGaD
Imiquimod—Asthenia—Procarbazine—brain cancer	0.000633	0.00211	CcSEcCtD
Imiquimod—Hepatobiliary disease—Etoposide—brain cancer	0.000633	0.00211	CcSEcCtD
Imiquimod—Back pain—Temozolomide—brain cancer	0.000632	0.0021	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CG—brain cancer	0.000629	0.0281	CbGpPWpGaD
Imiquimod—Pruritus—Procarbazine—brain cancer	0.000624	0.00208	CcSEcCtD
Imiquimod—Agitation—Carmustine—brain cancer	0.000621	0.00207	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—SPP1—brain cancer	0.000615	0.0274	CbGpPWpGaD
Imiquimod—Dyspnoea—Hydroxyurea—brain cancer	0.000609	0.00203	CcSEcCtD
Imiquimod—Somnolence—Hydroxyurea—brain cancer	0.000607	0.00202	CcSEcCtD
Imiquimod—Ill-defined disorder—Temozolomide—brain cancer	0.000606	0.00202	CcSEcCtD
Imiquimod—Diarrhoea—Procarbazine—brain cancer	0.000603	0.00201	CcSEcCtD
Imiquimod—Dyspepsia—Hydroxyurea—brain cancer	0.000601	0.002	CcSEcCtD
Imiquimod—Agitation—Temozolomide—brain cancer	0.0006	0.002	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—SPP1—brain cancer	0.000597	0.0266	CbGpPWpGaD
Imiquimod—Angioedema—Temozolomide—brain cancer	0.000597	0.00199	CcSEcCtD
Imiquimod—Decreased appetite—Hydroxyurea—brain cancer	0.000593	0.00197	CcSEcCtD
Imiquimod—Urinary tract disorder—Etoposide—brain cancer	0.000593	0.00197	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000589	0.00196	CcSEcCtD
Imiquimod—Malaise—Temozolomide—brain cancer	0.000589	0.00196	CcSEcCtD
Imiquimod—Urethral disorder—Etoposide—brain cancer	0.000589	0.00196	CcSEcCtD
Imiquimod—Fatigue—Hydroxyurea—brain cancer	0.000588	0.00196	CcSEcCtD
Imiquimod—Convulsion—Carmustine—brain cancer	0.000586	0.00195	CcSEcCtD
Imiquimod—Hypertension—Carmustine—brain cancer	0.000584	0.00194	CcSEcCtD
Imiquimod—Pain—Hydroxyurea—brain cancer	0.000584	0.00194	CcSEcCtD
Imiquimod—Dizziness—Procarbazine—brain cancer	0.000583	0.00194	CcSEcCtD
Imiquimod—Palpitations—Temozolomide—brain cancer	0.000577	0.00192	CcSEcCtD
Imiquimod—Myalgia—Carmustine—brain cancer	0.000576	0.00192	CcSEcCtD
Imiquimod—Chest pain—Carmustine—brain cancer	0.000576	0.00192	CcSEcCtD
Imiquimod—Anxiety—Carmustine—brain cancer	0.000574	0.00191	CcSEcCtD
Imiquimod—Cough—Temozolomide—brain cancer	0.00057	0.0019	CcSEcCtD
Imiquimod—Erythema multiforme—Etoposide—brain cancer	0.000568	0.00189	CcSEcCtD
Imiquimod—Convulsion—Temozolomide—brain cancer	0.000566	0.00188	CcSEcCtD
Imiquimod—Hypertension—Temozolomide—brain cancer	0.000564	0.00188	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—brain cancer	0.000564	0.0251	CbGpPWpGaD
Imiquimod—Feeling abnormal—Hydroxyurea—brain cancer	0.000562	0.00187	CcSEcCtD
Imiquimod—Eye disorder—Etoposide—brain cancer	0.000561	0.00187	CcSEcCtD
Imiquimod—Vomiting—Procarbazine—brain cancer	0.000561	0.00187	CcSEcCtD
Imiquimod—Flushing—Etoposide—brain cancer	0.000557	0.00186	CcSEcCtD
Imiquimod—Arthralgia—Temozolomide—brain cancer	0.000556	0.00185	CcSEcCtD
Imiquimod—Myalgia—Temozolomide—brain cancer	0.000556	0.00185	CcSEcCtD
Imiquimod—Rash—Procarbazine—brain cancer	0.000556	0.00185	CcSEcCtD
Imiquimod—Dermatitis—Procarbazine—brain cancer	0.000556	0.00185	CcSEcCtD
Imiquimod—Anxiety—Temozolomide—brain cancer	0.000554	0.00184	CcSEcCtD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—RELA—brain cancer	0.000553	0.0247	CbGpPWpGaD
Imiquimod—Headache—Procarbazine—brain cancer	0.000553	0.00184	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000552	0.00184	CcSEcCtD
Imiquimod—Oedema—Carmustine—brain cancer	0.000552	0.00184	CcSEcCtD
Imiquimod—Discomfort—Temozolomide—brain cancer	0.00055	0.00183	CcSEcCtD
Imiquimod—Infection—Carmustine—brain cancer	0.000548	0.00182	CcSEcCtD
Imiquimod—Angiopathy—Etoposide—brain cancer	0.000545	0.00181	CcSEcCtD
Imiquimod—Dry mouth—Temozolomide—brain cancer	0.000544	0.00181	CcSEcCtD
Imiquimod—Immune system disorder—Etoposide—brain cancer	0.000542	0.00181	CcSEcCtD
Imiquimod—Mediastinal disorder—Etoposide—brain cancer	0.000541	0.0018	CcSEcCtD
Imiquimod—Body temperature increased—Hydroxyurea—brain cancer	0.00054	0.0018	CcSEcCtD
Imiquimod—Chills—Etoposide—brain cancer	0.000539	0.00179	CcSEcCtD
Imiquimod—Tachycardia—Carmustine—brain cancer	0.000539	0.00179	CcSEcCtD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—RELA—brain cancer	0.000534	0.0238	CbGpPWpGaD
Imiquimod—Oedema—Temozolomide—brain cancer	0.000533	0.00177	CcSEcCtD
Imiquimod—Alopecia—Etoposide—brain cancer	0.000531	0.00177	CcSEcCtD
Imiquimod—Infection—Temozolomide—brain cancer	0.00053	0.00176	CcSEcCtD
Imiquimod—Anorexia—Carmustine—brain cancer	0.000526	0.00175	CcSEcCtD
Imiquimod—Nausea—Procarbazine—brain cancer	0.000524	0.00174	CcSEcCtD
Imiquimod—Nervous system disorder—Temozolomide—brain cancer	0.000523	0.00174	CcSEcCtD
Imiquimod—Skin disorder—Temozolomide—brain cancer	0.000518	0.00172	CcSEcCtD
Imiquimod—Hyperhidrosis—Temozolomide—brain cancer	0.000516	0.00172	CcSEcCtD
Imiquimod—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000515	0.023	CbGpPWpGaD
Imiquimod—Anorexia—Temozolomide—brain cancer	0.000508	0.00169	CcSEcCtD
Imiquimod—Back pain—Etoposide—brain cancer	0.000506	0.00168	CcSEcCtD
Imiquimod—Hypersensitivity—Hydroxyurea—brain cancer	0.000503	0.00167	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Carmustine—brain cancer	0.000503	0.00167	CcSEcCtD
Imiquimod—Insomnia—Carmustine—brain cancer	0.000499	0.00166	CcSEcCtD
Imiquimod—Paraesthesia—Carmustine—brain cancer	0.000495	0.00165	CcSEcCtD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000495	0.0221	CbGpPWpGaD
Imiquimod—Dyspnoea—Carmustine—brain cancer	0.000492	0.00164	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—RELA—brain cancer	0.000492	0.0219	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CG—brain cancer	0.000491	0.0219	CbGpPWpGaD
Imiquimod—Somnolence—Carmustine—brain cancer	0.000491	0.00163	CcSEcCtD
Imiquimod—Asthenia—Hydroxyurea—brain cancer	0.00049	0.00163	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000486	0.00162	CcSEcCtD
Imiquimod—Ill-defined disorder—Etoposide—brain cancer	0.000485	0.00161	CcSEcCtD
Imiquimod—Insomnia—Temozolomide—brain cancer	0.000482	0.00161	CcSEcCtD
Imiquimod—Decreased appetite—Carmustine—brain cancer	0.00048	0.0016	CcSEcCtD
Imiquimod—Paraesthesia—Temozolomide—brain cancer	0.000479	0.00159	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CG—brain cancer	0.000477	0.0213	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Carmustine—brain cancer	0.000476	0.00159	CcSEcCtD
Imiquimod—Dyspnoea—Temozolomide—brain cancer	0.000475	0.00158	CcSEcCtD
Imiquimod—Somnolence—Temozolomide—brain cancer	0.000474	0.00158	CcSEcCtD
Imiquimod—Pain—Carmustine—brain cancer	0.000472	0.00157	CcSEcCtD
Imiquimod—Malaise—Etoposide—brain cancer	0.000471	0.00157	CcSEcCtD
Imiquimod—Dyspepsia—Temozolomide—brain cancer	0.000469	0.00156	CcSEcCtD
Imiquimod—Diarrhoea—Hydroxyurea—brain cancer	0.000467	0.00155	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—SPP1—brain cancer	0.000466	0.0208	CbGpPWpGaD
Imiquimod—Decreased appetite—Temozolomide—brain cancer	0.000464	0.00154	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Temozolomide—brain cancer	0.00046	0.00153	CcSEcCtD
Imiquimod—Fatigue—Temozolomide—brain cancer	0.00046	0.00153	CcSEcCtD
Imiquimod—Loss of consciousness—Etoposide—brain cancer	0.00046	0.00153	CcSEcCtD
Imiquimod—Cough—Etoposide—brain cancer	0.000456	0.00152	CcSEcCtD
Imiquimod—Pain—Temozolomide—brain cancer	0.000456	0.00152	CcSEcCtD
Imiquimod—Feeling abnormal—Carmustine—brain cancer	0.000455	0.00151	CcSEcCtD
Imiquimod—Convulsion—Etoposide—brain cancer	0.000453	0.00151	CcSEcCtD
Imiquimod—Hypertension—Etoposide—brain cancer	0.000451	0.0015	CcSEcCtD
Imiquimod—Dizziness—Hydroxyurea—brain cancer	0.000451	0.0015	CcSEcCtD
Imiquimod—Gastrointestinal pain—Carmustine—brain cancer	0.000451	0.0015	CcSEcCtD
Imiquimod—Chest pain—Etoposide—brain cancer	0.000445	0.00148	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000442	0.00147	CcSEcCtD
Imiquimod—Discomfort—Etoposide—brain cancer	0.00044	0.00146	CcSEcCtD
Imiquimod—Feeling abnormal—Temozolomide—brain cancer	0.000439	0.00146	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000436	0.0195	CbGpPWpGaD
Imiquimod—Abdominal pain—Carmustine—brain cancer	0.000436	0.00145	CcSEcCtD
Imiquimod—Body temperature increased—Carmustine—brain cancer	0.000436	0.00145	CcSEcCtD
Imiquimod—Gastrointestinal pain—Temozolomide—brain cancer	0.000436	0.00145	CcSEcCtD
Imiquimod—Vomiting—Hydroxyurea—brain cancer	0.000434	0.00144	CcSEcCtD
Imiquimod—Rash—Hydroxyurea—brain cancer	0.00043	0.00143	CcSEcCtD
Imiquimod—Dermatitis—Hydroxyurea—brain cancer	0.00043	0.00143	CcSEcCtD
Imiquimod—Headache—Hydroxyurea—brain cancer	0.000428	0.00142	CcSEcCtD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—brain cancer	0.000427	0.019	CbGpPWpGaD
Imiquimod—Infection—Etoposide—brain cancer	0.000424	0.00141	CcSEcCtD
Imiquimod—Urticaria—Temozolomide—brain cancer	0.000424	0.00141	CcSEcCtD
Imiquimod—Abdominal pain—Temozolomide—brain cancer	0.000422	0.0014	CcSEcCtD
Imiquimod—Body temperature increased—Temozolomide—brain cancer	0.000422	0.0014	CcSEcCtD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—RELA—brain cancer	0.000419	0.0187	CbGpPWpGaD
Imiquimod—Tachycardia—Etoposide—brain cancer	0.000416	0.00139	CcSEcCtD
Imiquimod—Skin disorder—Etoposide—brain cancer	0.000414	0.00138	CcSEcCtD
Imiquimod—Hyperhidrosis—Etoposide—brain cancer	0.000413	0.00137	CcSEcCtD
Imiquimod—Anorexia—Etoposide—brain cancer	0.000407	0.00135	CcSEcCtD
Imiquimod—Hypersensitivity—Carmustine—brain cancer	0.000407	0.00135	CcSEcCtD
Imiquimod—Nausea—Hydroxyurea—brain cancer	0.000405	0.00135	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—RELA—brain cancer	0.000405	0.018	CbGpPWpGaD
Imiquimod—Asthenia—Carmustine—brain cancer	0.000396	0.00132	CcSEcCtD
Imiquimod—Hypersensitivity—Temozolomide—brain cancer	0.000393	0.00131	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	0.000384	0.0171	CbGpPWpGaD
Imiquimod—Paraesthesia—Etoposide—brain cancer	0.000383	0.00128	CcSEcCtD
Imiquimod—Asthenia—Temozolomide—brain cancer	0.000383	0.00127	CcSEcCtD
Imiquimod—Dyspnoea—Etoposide—brain cancer	0.00038	0.00127	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—RELA—brain cancer	0.00038	0.0169	CbGpPWpGaD
Imiquimod—Somnolence—Etoposide—brain cancer	0.000379	0.00126	CcSEcCtD
Imiquimod—Diarrhoea—Carmustine—brain cancer	0.000378	0.00126	CcSEcCtD
Imiquimod—Pruritus—Temozolomide—brain cancer	0.000377	0.00126	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—RELA—brain cancer	0.000373	0.0166	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CG—brain cancer	0.000372	0.0166	CbGpPWpGaD
Imiquimod—Decreased appetite—Etoposide—brain cancer	0.000371	0.00123	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Etoposide—brain cancer	0.000368	0.00123	CcSEcCtD
Imiquimod—Fatigue—Etoposide—brain cancer	0.000368	0.00122	CcSEcCtD
Imiquimod—Dizziness—Carmustine—brain cancer	0.000365	0.00121	CcSEcCtD
Imiquimod—Pain—Etoposide—brain cancer	0.000365	0.00121	CcSEcCtD
Imiquimod—Diarrhoea—Temozolomide—brain cancer	0.000365	0.00121	CcSEcCtD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000354	0.0158	CbGpPWpGaD
Imiquimod—Dizziness—Temozolomide—brain cancer	0.000353	0.00117	CcSEcCtD
Imiquimod—Feeling abnormal—Etoposide—brain cancer	0.000352	0.00117	CcSEcCtD
Imiquimod—Vomiting—Carmustine—brain cancer	0.000351	0.00117	CcSEcCtD
Imiquimod—Gastrointestinal pain—Etoposide—brain cancer	0.000349	0.00116	CcSEcCtD
Imiquimod—Rash—Carmustine—brain cancer	0.000348	0.00116	CcSEcCtD
Imiquimod—Dermatitis—Carmustine—brain cancer	0.000348	0.00116	CcSEcCtD
Imiquimod—Headache—Carmustine—brain cancer	0.000346	0.00115	CcSEcCtD
Imiquimod—Vomiting—Temozolomide—brain cancer	0.000339	0.00113	CcSEcCtD
Imiquimod—Urticaria—Etoposide—brain cancer	0.000339	0.00113	CcSEcCtD
Imiquimod—Body temperature increased—Etoposide—brain cancer	0.000337	0.00112	CcSEcCtD
Imiquimod—Abdominal pain—Etoposide—brain cancer	0.000337	0.00112	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000337	0.015	CbGpPWpGaD
Imiquimod—Rash—Temozolomide—brain cancer	0.000336	0.00112	CcSEcCtD
Imiquimod—Dermatitis—Temozolomide—brain cancer	0.000336	0.00112	CcSEcCtD
Imiquimod—Headache—Temozolomide—brain cancer	0.000334	0.00111	CcSEcCtD
Imiquimod—Nausea—Carmustine—brain cancer	0.000328	0.00109	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000321	0.0143	CbGpPWpGaD
Imiquimod—Nausea—Temozolomide—brain cancer	0.000317	0.00105	CcSEcCtD
Imiquimod—Hypersensitivity—Etoposide—brain cancer	0.000314	0.00105	CcSEcCtD
Imiquimod—Asthenia—Etoposide—brain cancer	0.000306	0.00102	CcSEcCtD
Imiquimod—Pruritus—Etoposide—brain cancer	0.000302	0.001	CcSEcCtD
Imiquimod—Diarrhoea—Etoposide—brain cancer	0.000292	0.000972	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	0.000291	0.013	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—RELA—brain cancer	0.000288	0.0128	CbGpPWpGaD
Imiquimod—Dizziness—Etoposide—brain cancer	0.000282	0.000939	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000277	0.0124	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000273	0.0122	CbGpPWpGaD
Imiquimod—Vomiting—Etoposide—brain cancer	0.000271	0.000903	CcSEcCtD
Imiquimod—Rash—Etoposide—brain cancer	0.000269	0.000895	CcSEcCtD
Imiquimod—Dermatitis—Etoposide—brain cancer	0.000269	0.000895	CcSEcCtD
Imiquimod—Headache—Etoposide—brain cancer	0.000267	0.00089	CcSEcCtD
Imiquimod—Nausea—Etoposide—brain cancer	0.000253	0.000844	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—VAV1—brain cancer	0.000248	0.011	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000225	0.01	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000214	0.00953	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000211	0.00941	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PDGFRA—brain cancer	0.000203	0.00905	CbGpPWpGaD
Imiquimod—TLR8—Immune System—SKP2—brain cancer	0.000189	0.00844	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—VAV1—brain cancer	0.000188	0.00837	CbGpPWpGaD
Imiquimod—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000182	0.0081	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IRS2—brain cancer	0.000178	0.00794	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000173	0.00773	CbGpPWpGaD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000161	0.00718	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PDGFRA—brain cancer	0.000154	0.00686	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000148	0.00659	CbGpPWpGaD
Imiquimod—TLR8—Immune System—VAV1—brain cancer	0.000144	0.00643	CbGpPWpGaD
Imiquimod—TLR7—Immune System—SKP2—brain cancer	0.000144	0.0064	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRS2—brain cancer	0.000135	0.00602	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000123	0.00549	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—RELA—brain cancer	0.000123	0.00548	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ERBB2—brain cancer	0.000122	0.00545	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000119	0.00532	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PDGFRA—brain cancer	0.000118	0.00527	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000118	0.00525	CbGpPWpGaD
Imiquimod—TLR7—Immune System—VAV1—brain cancer	0.000109	0.00488	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CTNNB1—brain cancer	0.000107	0.00476	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRS2—brain cancer	0.000104	0.00463	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—RELA—brain cancer	9.32e-05	0.00415	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ERBB2—brain cancer	9.26e-05	0.00413	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2C9—brain cancer	9.21e-05	0.0041	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	9.08e-05	0.00405	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PDGFRA—brain cancer	8.96e-05	0.00399	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EGFR—brain cancer	8.47e-05	0.00377	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CTNNB1—brain cancer	8.1e-05	0.00361	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRS2—brain cancer	7.86e-05	0.00351	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RELA—brain cancer	7.16e-05	0.00319	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ERBB2—brain cancer	7.12e-05	0.00317	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.1e-05	0.00316	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2—brain cancer	6.45e-05	0.00287	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EGFR—brain cancer	6.42e-05	0.00286	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	6.39e-05	0.00285	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CTNNB1—brain cancer	6.23e-05	0.00278	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.43e-05	0.00242	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RELA—brain cancer	5.43e-05	0.00242	CbGpPWpGaD
Imiquimod—TLR8—Immune System—STAT3—brain cancer	5.43e-05	0.00242	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ERBB2—brain cancer	5.39e-05	0.0024	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	5e-05	0.00223	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EGFR—brain cancer	4.93e-05	0.0022	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.89e-05	0.00218	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.89e-05	0.00218	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—brain cancer	4.89e-05	0.00218	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTNNB1—brain cancer	4.72e-05	0.0021	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.58e-05	0.00204	CbGpPWpGaD
Imiquimod—TLR7—Immune System—STAT3—brain cancer	4.11e-05	0.00183	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EGFR—brain cancer	3.74e-05	0.00167	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.35e-05	0.00149	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2C9—brain cancer	2.04e-05	0.000909	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BSG—brain cancer	1.73e-05	0.000773	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2C9—brain cancer	1.57e-05	0.000702	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—IDH1—brain cancer	1.49e-05	0.000665	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BSG—brain cancer	1.34e-05	0.000597	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000541	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO2—brain cancer	1.18e-05	0.000526	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—IDH1—brain cancer	1.15e-05	0.000513	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO2—brain cancer	9.1e-06	0.000406	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CG—brain cancer	5.41e-06	0.000241	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CG—brain cancer	4.18e-06	0.000186	CbGpPWpGaD
